Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FAF35
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $13,886.20 by the Defense Logistics Agency (DLA) for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a specific drawdown against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The SPE2DB vehicle, valued at $499,999,999 and valid through November 2026, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. This delivery order was awarded without set-aside designation.
Nexplanon implants are contraceptive devices that fall within the broader portfolio of pharmaceutical and medical products that DMS Pharmaceutical Group routinely supplies to federal healthcare systems. The company's established role as a critical supplier in the federal pharmaceutical supply chain reflects its capability to deliver prescription medications, biologics, and medical consumables directly to military health facilities. The DLA's utilization of this delivery order demonstrates the agency's reliance on DMS Pharmaceutical Group's distribution network to fulfill ongoing medical supply requirements across the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FAF35?
SPE2DB25FAF35 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FAF35 worth?
The government has obligated $13,886 on SPE2DB25FAF35.
Is contract SPE2DB25FAF35 an order under another contract?
Yes. SPE2DB25FAF35 is a delivery order under SPE2DB22D9309, an indefinite delivery contract.
Was contract SPE2DB25FAF35 competed?
The extent of competition for SPE2DB25FAF35 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award